InterventionsHumans
Metolazone and Alzheimer’s Disease Related Dementia (ADRD): Artificial Intelligence Approach To Drug Repurposing
GSA 2025 Abstract
Abstract
Currently, there is no drug approved for ADRD prevention. Developing new drugs is costly and time-consuming, and drug repurposing is rare and often serendipitous.
The paper
Washington DC VA Medical Center · United States Department of Veterans Affairs
GSA 2025 Abstract · 31 Dec 2025 · CC BY
Presented at GSA 2025
